SEC Form 4 · accession 0000899243-18-022326
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael A Klump
Director
Period of report
Aug 10, 2018
Accepted (ET)
Aug 14, 2018 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.47 | Aug 10, 2018 | A | 80,822 | A | — | Aug 10, 2028 | Common Stock | 80,822 | 80,822 | D |
Explanation of responses
- F1The options will vest commencing on September 1, 2018 with respect to 5,822 shares, and will vest in three equal quarterly installments commencing on December 1, 2018 with respect to the remaining shares.